POVTENZI
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

POVTENZI Trademark

Serial Number: 99714539

POVTENZI is a trademark filed by Vertex Pharmaceuticals Incorporated on March 20, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Vertex Pharmaceuticals Incorporated (3 trademarks)

50 Northern Avenue
Boston, MA 02210

Entity Type: 03

Trademark Details

Filing Date

March 20, 2026

Registration Date

Not Registered

Published for Opposition

September 8, 2026

Goods & Services

pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 11, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 11, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Aug 11, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Aug 11, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 11, 2026 CNEA
ASSIGNED TO EXAMINER
Aug 6, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 5, 2026 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 20, 2026 MAFR
NEW APPLICATION ENTERED
Mar 20, 2026 NWAP